R1 RCM Inc. (NASDAQ:RCM) Receives Consensus Recommendation of “Hold” from Brokerages

R1 RCM Inc. (NASDAQ:RCM) has been assigned an average recommendation of “Hold” from the eighteen ratings firms that are covering the firm, Marketbeat Ratings reports. Thirteen equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $15.41.

A number of brokerages have weighed in on RCM. TD Cowen reaffirmed a “hold” rating and set a $14.30 price target (down from $20.00) on shares of R1 RCM in a research report on Monday, August 5th. Leerink Partners cut shares of R1 RCM from an “outperform” rating to a “market perform” rating and reduced their price target for the company from $17.00 to $14.30 in a research report on Thursday, August 1st. Robert W. Baird reaffirmed an “outperform” rating and set a $18.00 price target on shares of R1 RCM in a research report on Tuesday, July 2nd. Deutsche Bank Aktiengesellschaft lifted their price target on shares of R1 RCM from $14.00 to $16.00 and gave the company a “hold” rating in a research report on Tuesday, July 9th. Finally, Morgan Stanley cut shares of R1 RCM from an “overweight” rating to an “equal weight” rating in a research report on Thursday, August 8th.

Hedge Funds Weigh In On R1 RCM

Institutional investors have recently modified their holdings of the company. Advisors Asset Management Inc. acquired a new stake in R1 RCM in the 1st quarter valued at about $27,000. ANTIPODES PARTNERS Ltd acquired a new stake in R1 RCM in the 2nd quarter valued at about $86,000. QRG Capital Management Inc. acquired a new stake in R1 RCM in the 1st quarter valued at about $132,000. Caas Capital Management LP acquired a new stake in R1 RCM in the 4th quarter valued at about $148,000. Finally, CIBC Asset Management Inc acquired a new stake in R1 RCM in the 2nd quarter valued at about $149,000. Institutional investors own 61.10% of the company’s stock.

R1 RCM Price Performance

R1 RCM stock opened at $14.19 on Wednesday. R1 RCM has a 12-month low of $8.87 and a 12-month high of $15.12. The stock has a market capitalization of $5.98 billion, a P/E ratio of -177.38 and a beta of 0.85. The firm’s 50-day moving average is $14.01 and its two-hundred day moving average is $13.04. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.84 and a quick ratio of 1.84.

R1 RCM (NASDAQ:RCM) last released its quarterly earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.03. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The company had revenue of $627.90 million for the quarter, compared to analysts’ expectations of $633.10 million. The firm’s quarterly revenue was up 12.0% compared to the same quarter last year. Equities analysts predict that R1 RCM will post -0.24 earnings per share for the current year.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.